The efficacy and safety of liraglutide added to metformin in patients with diabetes: a meta-analysis of randomized controlled trials

Liraglutide, a glucagon-like peptide (GLP-1) receptor agonist, has showed favorable effects in the glycaemic control and weight reduction in patients with type 2 diabetes mellitus (T2DM). The meta-analysis was to compare the efficacy and safety of liraglutide added to metformin with other treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Jianqiu, Meng, Xin, Guo, Yan, Wang, Lei, Zheng, Hongzhi, Liu, Yixuan, Wu, Bingshu, Wang, Difei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013324/
https://www.ncbi.nlm.nih.gov/pubmed/27600499
http://dx.doi.org/10.1038/srep32714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013324/
https://www.ncbi.nlm.nih.gov/pubmed/27600499
http://dx.doi.org/10.1038/srep32714

Ejemplares similares